News

Takeda said that study data shows that Actos can have a positive effect on several measures of cardiovascular disease outcomes in high-risk patients with type two diabetes. In

The letter relates to deficiencies in the way that Actavis has handled its adverse medical event reporting obligations and also questions the marketing status of certain of Actavis’s

The pivotal study will include a maximum of 273 patients with squamous cell carcinoma of the head and neck (SCCHN) who are refractory to or intolerant of standard

The in vitro portion of this testing will require approximately six months to complete at which time the in vivo testing will begin. After six months of this

GE Bayer Silicones is a part of GE Advanced Materials, which GE earlier announced it is selling to New York-based Apollo Management for $3.8 billion. Bayer said that

The study findings point to talabostat’s ability to stimulate key cytokines known to play an important role in immunostimulation – the enhancement of the body’s natural defenses against

Upstream, which aims to become an emerging leader in the field of genetic diagnostics for cancer and the prediction of drug response, is developing diagnostic tests that may

GX15-070 is specifically designed to inhibit all relevant members of the Bcl-2 protein family, a validated cancer target, thus restoring the natural cell death process of apoptosis. Phase

During the one month safety and tolerability study for the drug, several cases of asymptomatic elevated liver function tests in the group of elderly volunteers were observed. No